US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

29.00

-0.5800-1.96%

Post-market: 29.000.00000.00%19:54 EDT

Volume:156.51K

Turnover:4.55M

Market Cap:816.24M

PE:-16.39

High:29.52

Open:28.80

Low:28.57

Close:29.58

Loading ...

Overview Company News Filings

Crispr Therapeutics AG: Stock Soars Amid Bullish Trends

Rakovina Therapeutics Secures $4.9 Million in Oversubscribed Private Placement

Stocks to Watch: Children's Place, Tempest Therapeutics

Intensity Therapeutics Faces Nasdaq Delisting Notice

Plus Therapeutics Appeals Nasdaq Delisting Decision

Keros Therapeutics CEO to Speak at Healthcare Conference

Beam Therapeutics Confirms Key Decisions at Annual Meeting

Tempest Therapeutics Shifts Executives to Consulting Roles

Vera Therapeutics Down Over 28%, on Track for Largest Percent Decrease Since January 2023 -- Data Talk

Ascendiant Reaffirms Their Buy Rating on Atossa Therapeutics (ATOS)

Kazia Therapeutics: Strategic Advancements and Market Opportunities Reinforce Buy Rating

CERo Therapeutics Completes Series D Stock Issuance

Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating

Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data

Buy Rating for Vera Therapeutics: Promising Atacicept Data and Market Potential in IgAN Treatment

Addex Therapeutics Reports Promising Preclinical Results for Chronic Cough Treatment

Arcturus Therapeutics: Strategic Shift to Rare Disease Therapeutics and Strong Financial Position Drive Buy Rating

Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity

Avalo Therapeutics Signs New Sales Agreement

Quince Therapeutics Approves Key Proposals at Annual Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LENZ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":29,"timestamp":1749844800000,"preClose":29.58,"halted":0,"volume":156505,"hourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"delay":0,"floatShares":11653723,"shares":28146154,"eps":-1.769251,"marketStatus":"Market Closed","change":-0.58,"latestTime":"06-13 16:00:00 EDT","open":28.8,"high":29.52,"low":28.565,"amount":4554492.6963,"amplitude":0.032285,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.769251,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1750060800000},"marketStatusCode":7,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":29.58,"preHourTrading":{"tag":"盘前","latestPrice":28.84,"preClose":29.58,"latestTime":"09:29 EDT","volume":77,"amount":2235.719948,"timestamp":1749821370092},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:54 EDT","volume":608,"amount":17570.81,"timestamp":1749858862399},"volumeRatio":0.2990981094374136,"impliedVol":0.5592,"impliedVolPercentile":0.5435},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":11653723,"roa":"-17.75%","roe":"-24.47%","lyrEps":-2.338654,"volumeRatio":0.2990981094374136,"shares":28146154,"dividePrice":0,"high":29.52,"amplitude":0.032285,"preClose":29.58,"low":28.565,"week52Low":16.28,"pbRate":"4.25","week52High":38.93,"institutionHeld":0,"latestPrice":29,"eps":-1.769251,"divideRate":0,"volume":156505,"delay":0,"ttmEps":-1.769251,"open":28.8,"prevYearClose":28.87,"prevWeekClose":31.96,"prevMonthClose":29.2,"prevQuarterClose":25.71,"fiveDayClose":31.96,"twentyDayClose":27.34,"sixtyDayClose":25.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541817597","title":"Crispr Therapeutics AG: Stock Soars Amid Bullish Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=2541817597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541817597?lang=en_us&edition=fundamental","pubTime":"2025-06-07 22:01","pubTimestamp":1749304889,"startTime":"0","endTime":"0","summary":"Crispr Therapeutics AG ( ($CRSP) ) has risen by 13.29%. Read on to learn why. Crispr Therapeutics AG has seen a notable increase in its stock price...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-bullish-trends?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/crispr-therapeutics-ag-stock-soars-amid-bullish-trends?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LU1861559042.SGD","BK4556","BK4588","BK4611","BK4007","BK4139","CRSP","LU1861558580.USD","BK4210","LENZ","BK4585","AG"],"gpt_icon":0},{"id":"2541813117","title":"Rakovina Therapeutics Secures $4.9 Million in Oversubscribed Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2541813117","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541813117?lang=en_us&edition=fundamental","pubTime":"2025-06-07 13:32","pubTimestamp":1749274348,"startTime":"0","endTime":"0","summary":"Rakovina Therapeutics Inc ( ($TSE:RKV) ) just unveiled an update. Rakovina Therapeutics Inc. announced the successful closing of an oversubscribed ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-secures-4-9-million-in-oversubscribed-private-placement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/rakovina-therapeutics-secures-4-9-million-in-oversubscribed-private-placement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2541896440","title":"Stocks to Watch: Children's Place, Tempest Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2541896440","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541896440?lang=en_us&edition=fundamental","pubTime":"2025-06-07 06:25","pubTimestamp":1749248700,"startTime":"0","endTime":"0","summary":"Children's Place posted a decline in same-store and overall sales in the first quarter. Management said uncertainty from tariffs and low consumer sentiment are putting pressure on finances. Shares sank 23% to $5.24 in postmarket trading Friday.Tempest Therapeutics said three of its c-suite executives transitioned to consulting agreements. The agreements have one-year terms and come as the cancer-treatment company is exploring strategic alternatives. Shares rose 7% to $8.80 after the market closed Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","TPST","LENZ","BK4007","PLCE","BK4139","BK4094"],"gpt_icon":0},{"id":"2541989502","title":"Intensity Therapeutics Faces Nasdaq Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2541989502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541989502?lang=en_us&edition=fundamental","pubTime":"2025-06-07 05:29","pubTimestamp":1749245394,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Intensity Therapeutics, Inc. ( ($INTS) ). On June 6, 2025, Intensity Therapeutics, Inc. received a notification...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-faces-nasdaq-delisting-notice?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/intensity-therapeutics-faces-nasdaq-delisting-notice?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["USJW.SI","PSQ","IE00B3QW5Z07.USD","BK4112","BK4539","MNQmain","BK4007","LU2210149790.SGD","SQQQ","USAW.SI","LU2095319765.USD","LENZ","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","NQmain","BK4588","NVIW.SI",".IXIC","QID","TSYW.SI","BK4139","QLD","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","TQQQ"],"gpt_icon":0},{"id":"2541843895","title":"Plus Therapeutics Appeals Nasdaq Delisting Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2541843895","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541843895?lang=en_us&edition=fundamental","pubTime":"2025-06-07 05:00","pubTimestamp":1749243636,"startTime":"0","endTime":"0","summary":"Plus Therapeutics ( ($PSTV) ) just unveiled an update. On June 3, 2025, Plus Therapeutics, Inc. received a letter from Nasdaq stating that the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-appeals-nasdaq-delisting-decision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/plus-therapeutics-appeals-nasdaq-delisting-decision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":[".IXIC","LU2095319765.USD","NDAQ","BK4112","NQmain","IE00B64PRP62.GBP","LU2210149790.SGD","BK4539","MNQmain","IE00B3QW5Z07.USD","USJW.SI","TQQQ","BK4585","USAW.SI","TSYW.SI","QLD","NVIW.SI","SQQQ","IE00BKPKM429.USD","BK4007","BK4139","LENZ","QID","LU2210150020.SGD","IE00BGHQF748.EUR","BK4588","PSQ"],"gpt_icon":0},{"id":"2541895849","title":"Keros Therapeutics CEO to Speak at Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2541895849","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541895849?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:47","pubTimestamp":1749242845,"startTime":"0","endTime":"0","summary":"Keros Therapeutics ( ($KROS) ) has issued an announcement. On June 6, 2025, Keros Therapeutics announced that its Chair and CEO, Jasbir Seehra, wil...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-ceo-to-speak-at-healthcare-conference-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-ceo-to-speak-at-healthcare-conference-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4007","BK4539","BK4139","LENZ","HCSG","KROS"],"gpt_icon":0},{"id":"2541895894","title":"Beam Therapeutics Confirms Key Decisions at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541895894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541895894?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:45","pubTimestamp":1749242749,"startTime":"0","endTime":"0","summary":"Beam Therapeutics ( ($BEAM) ) has provided an announcement. On June 4, 2025, Beam Therapeutics held its annual meeting of stockholders, where key d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-confirms-key-decisions-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beam-therapeutics-confirms-key-decisions-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4505","BK4585","BK4588","BK4535","BK4611","BEAM","BK4556","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2541127893","title":"Tempest Therapeutics Shifts Executives to Consulting Roles","url":"https://stock-news.laohu8.com/highlight/detail?id=2541127893","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541127893?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:39","pubTimestamp":1749242391,"startTime":"0","endTime":"0","summary":"Tempest Therapeutics ( ($TPST) ) has issued an announcement. Tempest Therapeutics announced a strategic shift on June 5, 2025, transitioning key ex...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tempest-therapeutics-shifts-executives-to-consulting-roles?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tempest-therapeutics-shifts-executives-to-consulting-roles?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"gpt_icon":0},{"id":"2541678068","title":"Vera Therapeutics Down Over 28%, on Track for Largest Percent Decrease Since January 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2541678068","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541678068?lang=en_us&edition=fundamental","pubTime":"2025-06-07 02:12","pubTimestamp":1749233520,"startTime":"0","endTime":"0","summary":"Vera Therapeutics, Inc. Class A  is currently at $21.86, down $8.78 or 28.65%. --On pace for largest percent decrease since Jan. 4, 2023, when it fell 64.7%. --Currently down two consecutive days; down 31.69% over this period. --Down 56.07% from its all-time closing high of $49.75 on Nov. 29, 2024. --Down 43.23% from 52 weeks ago , when it closed at $38.50. --Up 15.88% from its 52-week closing low of $18.86 on April 8, 2025. --Down 33.07% at today's intraday low; largest intraday percent decrease since Jan. 4, 2023, when it fell as much as 66.07%","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VERA","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2541287862","title":"Ascendiant Reaffirms Their Buy Rating on Atossa Therapeutics (ATOS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2541287862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541287862?lang=en_us&edition=fundamental","pubTime":"2025-06-07 01:25","pubTimestamp":1749230716,"startTime":"0","endTime":"0","summary":"In a report released today, Edward Woo from Ascendiant maintained a Buy rating on Atossa Therapeutics (ATOS – Research Report), with a price target...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ascendiant-reaffirms-their-buy-rating-on-atossa-therapeutics-atos-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ascendiant-reaffirms-their-buy-rating-on-atossa-therapeutics-atos-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATOS","LENZ"],"gpt_icon":0},{"id":"2541861507","title":"Kazia Therapeutics: Strategic Advancements and Market Opportunities Reinforce Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2541861507","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541861507?lang=en_us&edition=fundamental","pubTime":"2025-06-06 23:35","pubTimestamp":1749224112,"startTime":"0","endTime":"0","summary":"Naz Rahman, an analyst from Maxim Group, reiterated the Buy rating on Kazia Therapeutics (KZIA – Research Report). The associated price target rema...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kazia-therapeutics-strategic-advancements-and-market-opportunities-reinforce-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kazia-therapeutics-strategic-advancements-and-market-opportunities-reinforce-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2541985070","title":"CERo Therapeutics Completes Series D Stock Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2541985070","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541985070?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:57","pubTimestamp":1749214654,"startTime":"0","endTime":"0","summary":"CERo Therapeutics Holdings ( ($CERO) ) has issued an update. On June 5, 2025, CERo Therapeutics Holdings completed an additional closing of its Ser...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-completes-series-d-stock-issuance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cero-therapeutics-completes-series-d-stock-issuance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2541850098","title":"Structure Therapeutics, Inc.: Catalyst-Rich Outlook and Strategic Preparations Support Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2541850098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541850098?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:56","pubTimestamp":1749214567,"startTime":"0","endTime":"0","summary":"Jefferies analyst Roger Song maintained a Buy rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR – Research Report) yesterday and set a pri...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/structure-therapeutics-inc-catalyst-rich-outlook-and-strategic-preparations-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/structure-therapeutics-inc-catalyst-rich-outlook-and-strategic-preparations-support-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2541850033","title":"Vera Therapeutics drops 30% after rival Otsuka presents Phase 3 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2541850033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541850033?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:55","pubTimestamp":1749214517,"startTime":"0","endTime":"0","summary":"Shares of Vera Therapeutics (VERA) dropped nearly 30% in premarket trading after rival Otsuka (OTSKY) presented results from a pre-specified interi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-drops-30-after-rival-otsuka-presents-phase-3-data-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vera-therapeutics-drops-30-after-rival-otsuka-presents-phase-3-data-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","LENZ","BK4585","VERA","BK4007","BK4539","OTSKY"],"gpt_icon":0},{"id":"2541850546","title":"Buy Rating for Vera Therapeutics: Promising Atacicept Data and Market Potential in IgAN Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541850546","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541850546?lang=en_us&edition=fundamental","pubTime":"2025-06-06 20:45","pubTimestamp":1749213923,"startTime":"0","endTime":"0","summary":"Analyst Rami Katkhuda of LifeSci Capital maintained a Buy rating on Vera Therapeutics (VERA – Research Report), retaining the price target of $70.0...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-for-vera-therapeutics-promising-atacicept-data-and-market-potential-in-igan-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-for-vera-therapeutics-promising-atacicept-data-and-market-potential-in-igan-treatment-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","VERA"],"gpt_icon":0},{"id":"2541188717","title":"Addex Therapeutics Reports Promising Preclinical Results for Chronic Cough Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2541188717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541188717?lang=en_us&edition=fundamental","pubTime":"2025-06-06 13:33","pubTimestamp":1749187997,"startTime":"0","endTime":"0","summary":"The latest update is out from Addex Therapeutics ( ($CH:ADXN) ). Addex Therapeutics announced promising preclinical results for its GABAB positive ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-reports-promising-preclinical-results-for-chronic-cough-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/addex-therapeutics-reports-promising-preclinical-results-for-chronic-cough-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4539","BK4007"],"gpt_icon":0},{"id":"2541009652","title":"Arcturus Therapeutics: Strategic Shift to Rare Disease Therapeutics and Strong Financial Position Drive Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2541009652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541009652?lang=en_us&edition=fundamental","pubTime":"2025-06-06 05:15","pubTimestamp":1749158123,"startTime":"0","endTime":"0","summary":"William Blair analyst Myles Minter has maintained their bullish stance on ARCT stock, giving a Buy rating on May 28. Myles Minter has given his Buy...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/arcturus-therapeutics-strategic-shift-to-rare-disease-therapeutics-and-strong-financial-position-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/arcturus-therapeutics-strategic-shift-to-rare-disease-therapeutics-and-strong-financial-position-drive-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2541009616","title":"Rapt Therapeutics started at Buy at Clear Street on RPT904b opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2541009616","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541009616?lang=en_us&edition=fundamental","pubTime":"2025-06-06 05:10","pubTimestamp":1749157818,"startTime":"0","endTime":"0","summary":"Clear Street initiated coverage of Rapt Therapeutics (RAPT) with a Buy rating and $3 price target. The firm’s bullish call is driven by a strong co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rapt-therapeutics-started-at-buy-at-clear-street-on-rpt904b-opportunity-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rapt-therapeutics-started-at-buy-at-clear-street-on-rpt904b-opportunity-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","BK4539","RAPT"],"gpt_icon":0},{"id":"2541600699","title":"Avalo Therapeutics Signs New Sales Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2541600699","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541600699?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:34","pubTimestamp":1749155644,"startTime":"0","endTime":"0","summary":"An announcement from Avalo Therapeutics ( ($AVTX) ) is now available. On June 5, 2025, Avalo Therapeutics entered into a new Sales Agreement with T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avalo-therapeutics-signs-new-sales-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avalo-therapeutics-signs-new-sales-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ"],"gpt_icon":0},{"id":"2541913006","title":"Quince Therapeutics Approves Key Proposals at Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541913006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541913006?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:31","pubTimestamp":1749155469,"startTime":"0","endTime":"0","summary":"The latest update is out from Quince Therapeutics ( ($QNCX) ). On June 4, 2025, Quince Therapeutics, Inc. held its Annual Meeting of Stockholders o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quince-therapeutics-approves-key-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quince-therapeutics-approves-key-proposals-at-annual-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","LENZ","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":6,"totalSize":203,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-06-13","current":-17.439532,"percent":0.017422,"low":-18.842712,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"high":-5.069183,"avg":-10.841843,"sd":3.694257,"marketCap":832563235},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235}],"updateTime":1749979609838}}}